# OCR Desk Audit Evidence Package: MedDefense Health Systems

**Package date:** 2026-11-02  
**Prepared by:** IT Security — compliance assessment draft  
**Regulatory context:** HIPAA Security Rule, 45 CFR Part 164  
**Audit source:** `ocr_audit_letter.md`  
**Status:** Evidence inventory for review; not a representation that gaps have been remediated

## Scope and Evidence Rules

This package addresses the eight requests in `ocr_audit_letter.md`. Evidence status means **Full** (requested evidence complete and demonstrated), **Partial** (relevant evidence exists but is insufficient), or **None** (the requested evidence or acceptable substitute has not been provided). A policy draft does not prove approval, rollout, or enforcement. An action in a treatment plan does not prove completion. Source records include target dates in June–July 2026 that have passed as of this package date; no completion or extension is inferred. The source materials do not establish whether CloudVault has already received ePHI.

## OCR Evidence Requests

### Request 1: Security Risk Analysis

**HIPAA specification:** 164.308(a)(1)(ii)(A)  
**Evidence status:** Partial  
**Evidence description:** `risk_register_updates.yaml` documents five identified risks with severity and ownership; `forensic_findings_summary.md` identifies incident-derived vulnerabilities and threats; `endpoint_hardening_baseline.md` records assessed endpoint scope and exclusions; `hipaa_security_rule_crosswalk.md` maps the requirement to evidence.  
**Gap:** No documented organization-wide risk analysis methodology, likelihood/impact scoring criteria, complete ePHI asset and system scope, assessment approval, or evidence of periodic reassessment. Biomedical devices and some cloud environments are not fully covered. The incident-based risk register is not a substitute for a complete risk analysis.  
**Remediation owner and timeline:** IT Security Risk Lead and CISO — by **2026-11-16**, document methodology, scoring and scope; by **2026-12-14**, complete the ePHI-wide assessment and obtain dated CISO review.

### Request 2: Risk Management Plan

**HIPAA specification:** 164.308(a)(1)(ii)(B)  
**Evidence status:** Partial  
**Evidence description:** `risk_treatment_plan.md` assigns treatments, owners, targets, and success criteria for R-001 through R-005; `risk_register_updates.yaml` identifies open risks and owners; `vendor_management_policy.md` and `vendor_risk_assessment.md` document proposed vendor controls and a CloudVault rejection decision, not completed remediation.  
**Gap:** `risk_treatment_plan.md` explicitly lacks CISO sign-off and Board Risk Committee presentation. No evidence verifies that treatments were completed or revalidated. Its target dates (2026-06-01 through 2026-07-01) are overdue; the current risk register still shows risks open.  
**Remediation owner and timeline:** CISO and assigned risk owners — by **2026-11-16**, confirm actual status, rebaseline overdue actions and record approvals; by **2026-12-01**, submit closure evidence or documented interim controls for each open risk.

### Request 3: Workforce Security Awareness and Training

**HIPAA specification:** 164.308(a)(5)  
**Evidence status:** Partial  
**Evidence description:** `security_awareness_training_status.md` reports training for **2025-05-01 to 2026-04-30**, with **1,460 of 2,000** workforce members completing training (73%); it identifies subject matter covered and completion by workforce group. `risk_register_updates.yaml` lists the training gap as critical R-002. `acceptable_use_policy.md` is an unapproved draft and does not establish workforce acknowledgment.  
**Gap:** 540 workforce members lacked recorded completion for the reporting period; coverage is below the 95% internal target, contractor completion is 66%, role-based assignments and phishing simulation metrics are missing, and no newer completion records were supplied for the months after April 2026. The original treatment target of 2026-06-15 is overdue.  
**Remediation owner and timeline:** IT Security Training Lead and HR — by **2026-11-16**, export current, person-level training completion evidence; by **2026-12-02**, complete overdue training or document individual exceptions, contractor access controls, role-based assignments, and phishing metrics.

### Request 4: Audit Controls and System Activity Review

**HIPAA specification:** 164.312(b)  
**Evidence status:** Partial  
**Evidence description:** `sigma_detection_catalog.md` identifies six active detection rules and notes informal weekly SOC rule-performance reviews; `endpoint_hardening_baseline.md` documents Sysmon on **198 of 280** clinical Windows workstations, Linux auditd and partial log forwarding; `forensic_findings_summary.md` describes use of SIEM and Sysmon evidence during incident analysis; `risk_register_updates.yaml` tracks the DR CloudTrail gap as R-005.  
**Gap:** No dated, retained activity-review logs or reviewer sign-offs were provided. Endpoint logging is incomplete; PowerShell Script Block Logging and cloud DR-region CloudTrail are missing in parts of the environment, and biomedical devices do not forward logs. Detection rules alone do not prove routine review of all relevant system activity.  
**Remediation owner and timeline:** SOC Manager, Endpoint Engineering and Cloud Security — by **2026-11-16**, provide representative timestamped audit logs and signed review records; by **2026-12-02**, enable DR CloudTrail, address priority endpoint log gaps and formalize review cadence, ownership, and retention.

### Request 5: Workforce Security and Access Procedures

**HIPAA specification:** 164.308(a)(3)  
**Evidence status:** None  
**Evidence description:** **None** for documented user provisioning, termination, and periodic access review procedures and their execution records. `acceptable_use_policy.md` is a draft acceptable-use policy, not an access lifecycle procedure. `endpoint_hardening_baseline.md` describes limited technical account restrictions but explicitly does not prove periodic access review. `forensic_findings_summary.md` identifies excessive privileges for `svc_epic_int`.  
**Gap:** No approved joiner/mover/leaver procedure, access approval records, termination revocation evidence, periodic access recertification, or privileged/service-account review records were supplied.  
**Remediation owner and timeline:** IAM Lead, HR and IT Security — by **2026-11-16**, approve a role-based provisioning and termination procedure and collect recent ticket samples; by **2026-12-02**, complete and sign off an initial privileged-account and workforce access review with corrective actions tracked.

### Request 6: CloudVault Business Associate Agreement

**HIPAA specification:** 164.308(b)  
**Evidence status:** None  
**Evidence description:** **None** for an executed CloudVault BAA or evidence that CloudVault has not received ePHI. `baa_status_note.md` states that no BAA is executed; `cloudvault_contract_summary.md` describes proposed clinical backup data containing ePHI; `vendor_risk_assessment.md` recommends **Do Not Approve**; `vendor_management_policy.md` requires a signed BAA before Tier A ePHI access, but is pending CISO approval.  
**Gap:** CloudVault is expected to handle ePHI, yet no executed BAA exists. The supplied evidence does not confirm whether ePHI access or transfer has begun. Vendor willingness to sign is not an executed agreement, and an onboarding-block recommendation is not proof that access is blocked.  
**Remediation owner and timeline:** Legal (Helena Reyes), IT Security, Procurement and Infrastructure — **immediately**, verify and document whether CloudVault accounts, integrations, backups or ePHI transfers exist; by **2026-11-09**, submit signed evidence of no ePHI access and a verified access block **or** an executed, compliant BAA if engagement is to proceed. Do not authorize ePHI access before execution and completion of all Tier A security gates.

### Request 7: Periodic Technical Evaluation

**HIPAA specification:** 164.308(a)(8)  
**Evidence status:** Partial  
**Evidence description:** `endpoint_hardening_baseline.md` records a technical assessment dated **2026-04-18**, including endpoint scope, control deployment and exclusions; `sigma_detection_catalog.md` documents detection coverage as of **2026-04-22**; `recovery_validation_summary.md` documents a **2026-04-20** partial LIS recovery test. These artifacts fall within the 12 months before this package date.  
**Gap:** No consolidated, formally approved periodic technical evaluation across relevant systems and ePHI environments was supplied. Domain controllers and medical devices were excluded from endpoint hardening; cloud logging coverage, remediation verification, and management sign-off remain incomplete. A recovery tabletop does not replace a comprehensive technical evaluation.  
**Remediation owner and timeline:** IT Security Assurance Lead, Infrastructure and Biomedical IT — by **2026-11-23**, document an evaluation plan and missing-system scope; by **2026-12-14**, conduct or consolidate the technical evaluation, record findings and exceptions, and obtain CISO review.

### Request 8: Incident Response Procedures and Testing

**HIPAA specification:** 164.308(a)(6)  
**Evidence status:** Partial  
**Evidence description:** `ir_playbook_index.md` lists active credential-exposure, phishing, ransomware and data-exfiltration procedures; it records April 2026 tabletop tests and a phishing incident activation on **2026-04-09**. `forensic_findings_summary.md` documents the **2026-03-25 to 2026-03-26** Nexus/Cobalt Strike investigation. The recorded events fall within the requested 24-month window.  
**Gap:** The index is evidence that tests or activations occurred but the underlying exercise records and incident execution logs were not supplied as separate auditable artifacts. Vendor-originated and cloud incident playbooks remain drafts or untested; the annual exercise schedule, communications testing and CISO sign-off are missing.  
**Remediation owner and timeline:** Incident Response Lead and CISO — by **2026-11-16**, collect dated exercise reports, attendance, findings and incident records; by **2026-12-02**, approve the annual testing schedule and complete or schedule vendor-originated/cloud exercises with documented communications testing.

## Readiness Summary

| Evidence status | Requests |
| --- | ---: |
| Full | 0 |
| Partial | 6 |
| None | 2 |
| **Total** | **8** |

**Overall audit readiness:** **Not Ready**.

**Single biggest auditor-facing gap:** Request 6 lacks both an executed CloudVault BAA and documentary proof that no ePHI access has begun, leaving a potentially direct business-associate compliance exposure unresolved.

**Submission note:** The proposed remediation dates above are planning deadlines established for this package, **not** dates approved by MedDefense or proof of completed work. The earlier risk-treatment deadlines have passed without closure evidence. `data_classification_policy.md` was listed as an input but was not available among the provided files at package preparation; its existence, approval and distribution cannot be asserted. Draft policies (`acceptable_use_policy.md`, `vendor_management_policy.md`) and the proposed CloudVault assessment do not independently establish operational adoption. OCR reviewers should receive the named underlying artifacts and dated approvals, access records, logs and signed agreements as these become available.
